Acrivon Therapeutics, Inc. (ACRV) vs Rallybio Corporation (RLYB)
Acrivon Therapeutics, Inc. and Rallybio Corporation are both Biotechnology companies. Acrivon Therapeutics, Inc. and Rallybio Corporation are of similar size ($90.9M and $88.2M). Acrivon Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.1×. Across the 10 metrics below, Rallybio Corporation leads on 8 and Acrivon Therapeutics, Inc. on 2.
Valuation
Profitability
| Metric | ACRV | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (64.63%) | 64.86% | (57.72%) |
| Return on assets | (57.61%) | 61.12% | (49.22%) |
| Return on invested capital | 0.00% | (1,052.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack